2022
DOI: 10.1016/j.cej.2022.136295
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione responsive nitric oxide release for enhanced photodynamic therapy by a porphyrinic MOF nanosystem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
20
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 44 publications
(20 citation statements)
references
References 39 publications
0
20
0
Order By: Relevance
“…Fortunately, the development of catalysts, including catalytic nanomaterials and nano‐enzymes, provides a new way to build a controllable and persistent NO‐releasing system. [ 42–44 ] Recent research found that advanced catalytic nanomaterials (including nanozymes) not only have the characteristics of high drug payload, low toxicity, good biocompatibility, and specific drug delivery through passive (enhanced permeability and retention, EPR) or active targeting but also own the capability of continuous releasing NO through catalytic reaction, which might significantly increase the feasibility of NO‐based therapies. [ 45–48 ] Within this context, there have been many efforts in designing and fabricating NO‐releasing platforms based on catalytic nanomaterials, and therefore, significant progress has been achieved in many biomedical applications.…”
Section: Introductionmentioning
confidence: 99%
“…Fortunately, the development of catalysts, including catalytic nanomaterials and nano‐enzymes, provides a new way to build a controllable and persistent NO‐releasing system. [ 42–44 ] Recent research found that advanced catalytic nanomaterials (including nanozymes) not only have the characteristics of high drug payload, low toxicity, good biocompatibility, and specific drug delivery through passive (enhanced permeability and retention, EPR) or active targeting but also own the capability of continuous releasing NO through catalytic reaction, which might significantly increase the feasibility of NO‐based therapies. [ 45–48 ] Within this context, there have been many efforts in designing and fabricating NO‐releasing platforms based on catalytic nanomaterials, and therefore, significant progress has been achieved in many biomedical applications.…”
Section: Introductionmentioning
confidence: 99%
“…These characters of NO made itself a strong therapeutic agent in anti-tumor, anti-bacterial and anti-fungal applications. [13][14][15][16][17] In addition, NO was reported to enhance the conventional therapy in different ways. Yu et al reported a mesoporous polydopamine nanocomposite bearing deferoxamine and NO-donation macromolecular for NO enhanced antibacterial chemo-photothermal therapy.…”
Section: Introductionmentioning
confidence: 99%
“…These reactive substances will lead to intense membrane damage by causing oxidative stress and nitrosative stress. These characters of NO made itself a strong therapeutic agent in anti‐tumor, anti‐bacterial and anti‐fungal applications [13–17] . In addition, NO was reported to enhance the conventional therapy in different ways.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations